Benzinga's Top Upgrades
Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.
Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.
Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.
Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.
Latest Ratings for TEVA
|Jan 2017||Bank of America||Upgrades||Neutral||Buy|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.